Literature DB >> 31685151

Association of Fitness and Grip Strength With Heart Failure: Findings From the UK Biobank Population-Based Study.

Anne Sillars1, Carlos A Celis-Morales2, Frederick K Ho3, Fanny Petermann3, Paul Welsh1, Stamatina Iliodromiti1, Lyn D Ferguson1, Donald M Lyall4, Jana Anderson4, Daniel F Mackay4, Pierpaolo Pellicori5, John Cleland5, Jill P Pell4, Jason M R Gill1, Stuart R Gray1, Naveed Sattar1.   

Abstract

OBJECTIVE: To investigate the associations of objectively measured cardiorespiratory fitness (CRF) and grip strength (GS) with incident heart failure (HF), a clinical syndrome that results in substantial social and economic burden, using UK Biobank data. PATIENTS AND METHODS: Of the 502,628 participants recruited into the UK Biobank between April 1, 2007, and December 31, 2010, a total of 374,493 were included in our GS analysis and 57,053 were included in CRF analysis. Associations between CRF and GS and incident HF were investigated using Cox proportional hazard models, with adjustment for known measured confounders.
RESULTS: During a mean of 4.1 (range, 2.4-7.1) years, 631 HF events occurred in those with GS data, and 66 HF events occurred in those with CRF data. Higher CRF was associated with 18% lower risk for HF (hazard ratio [HR], 0.82; 95% CI, 0.76-0.88) per 1-metabolic equivalent increment increase and GS was associated with 19% lower incidence of HF risk (HR, 0.81; 95% CI, 0.77-0.86) per 5-kg increment increase. When CRF and GS were standardized, the HR for CRF was 0.50 per 1-SD increment (95% CI, 0.38-0.65), and for GS was 0.65 per 1-SD increment (95% CI, 0.58-0.72).
CONCLUSION: Our data indicate that objective measurements of physical function (GS and CRF) are strongly and independently associated with lower HF incidence. Future studies targeting improving CRF and muscle strength should include HF as an outcome to assess whether these results are causal.
Copyright © 2019 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31685151     DOI: 10.1016/j.mayocp.2019.04.041

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  8 in total

1.  The year in cardiology: heart failure.

Authors:  John G F Cleland; Alexander R Lyon; Theresa McDonagh; John J V McMurray
Journal:  Eur Heart J       Date:  2020-03-21       Impact factor: 29.983

2.  Prognostic value of malnutrition evaluated using the Global Leadership Initiative on Malnutrition criteria and its association with psoas muscle volume in non-ischemic dilated cardiomyopathy.

Authors:  Ryota Ito; Hiroaki Hiraiwa; Takashi Araki; Takashi Mizutani; Shingo Kazama; Yuki Kimura; Hideo Oishi; Tasuku Kuwayama; Toru Kondo; Ryota Morimoto; Takahiro Okumura; Toyoaki Murohara
Journal:  Heart Vessels       Date:  2022-06-14       Impact factor: 1.814

3.  Multi-system trajectories and the incidence of heart failure in the Framingham Offspring Study.

Authors:  Cara E Guardino; Stephanie Pan; Ramachandran S Vasan; Vanessa Xanthakis
Journal:  PLoS One       Date:  2022-05-26       Impact factor: 3.752

4.  Socioeconomic and behavioral determinants of cardiovascular diseases among older adults in Belgium and France: A longitudinal analysis from the SHARE study.

Authors:  Hamid Yimam Hassen; Hilde Bastiaens; Kathleen Van Royen; Steven Abrams
Journal:  PLoS One       Date:  2020-12-04       Impact factor: 3.240

5.  Targeted Genetic Reduction of Mutant Huntingtin Lessens Cardiac Pathology in the BACHD Mouse Model of Huntington's Disease.

Authors:  Saemi Park; Shu Hon Christopher Luk; Raj S Bains; Daniel S Whittaker; Emily Chiem; Maria C Jordan; Kenneth P Roos; Cristina A Ghiani; Christopher S Colwell
Journal:  Front Cardiovasc Med       Date:  2021-12-24

6.  Handgrip strength as an indicator for death events in China: A longitudinal cohort study.

Authors:  Kaihong Xie; Zhaojun Lu; Xiao Han; Meijia Huang; Junping Wang; Shou Kou; Weihao Wang; Sufang Zhuang; Weijun Zheng
Journal:  PLoS One       Date:  2022-10-13       Impact factor: 3.752

7.  Trends in Frailty and Use of Evidence-Based Pharmacotherapy for Heart Failure in Australian Hospitalised Patients: An Observational Study.

Authors:  Yogesh Sharma; Chris Horwood; Paul Hakendorf; Campbell Thompson
Journal:  J Clin Med       Date:  2021-12-10       Impact factor: 4.241

8.  Cardiorespiratory fitness assessment using risk-stratified exercise testing and dose-response relationships with disease outcomes.

Authors:  Tomas I Gonzales; Kate Westgate; Tessa Strain; Stefanie Hollidge; Justin Jeon; Dirk L Christensen; Jorgen Jensen; Nicholas J Wareham; Søren Brage
Journal:  Sci Rep       Date:  2021-07-28       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.